Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists von Tecle, H., Lauffer, D.J., Mirzadegan, T., Moos, W.H., Moreland, D.W., Pavia, M.R., Schwarz, R.D., Davis, R.E.

Volltext

Molecular modeling studies of the m1 and m2 muscarinic receptors leading to the design of selective m1 agonists von Mirzadegan, T., Tecle, H., Lauffer, D.J., Humblet, C.

Volltext

Aryleneyne 1-azabicyclo[2.2.1]heptan-3-one oximes: Potent muscarinic agonists von Tecle, H., Lauffer, D.J., Davis, R.E., Mirzadegan, T., Moreland, D.W., Schwarz, R.D., Thomas, A.J., Raby, C., Jaen, J.C.

Volltext

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology von Tecle, H, Schwarz, R.D, Barrett, S.D, Callahan, M.J, Caprathe, B.W, Davis, R.E, Doyle, P, Emmerling, M, Lauffer, D.J, Mirzadegan, T, Moreland, D.W, Lipiniski, W, Nelson, C, Raby, C, Spencer, C, Spiegel, K, Thomas, A.J, Jaen, J.C

Volltext

(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists von Tecle, H., Lauffer, D.J., Davis, R.E., Mirzadegan, T., Moreland, D.W., Schwan, R.D., Thomas, A.J., Raby, C., Eubanks, D., Brann, M.R., Jaen, J.C.

Volltext

Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes as potential m1-subtype selective muscarinic agonists von Tecle, H., Jaen, J.C., Augelli-Szafran, C., Barrett, S.D., Caprathe, B.W., Lauffer, D.J., Mirzadegan, T., Moos, W.H., Moreland, D.W., Pavia, M.R., Schwarz, R.D., Thomas, A.J., Davis, R.E.

Volltext